Duavee

    Drug - Duavee™ (conjugated estrogens/bazedoxifene) [Pfizer]

    November 2014

    Therapeutic area - Estrogen replacement/osteoporosis prevention

    Approval criteria

    • Patient has tried and failed alendronate AND
    • Patient has tried and failed ibandronate AND 
    • Patient has tried and failed at least one oral or transdermal estrogen product 

    Quantity limit

    Quantity limit = 34 

    Questions?

    MHCP Provider Call Center 651-431-2700 or 800-366-5411

    back to top